ALINITY C A1 ANTITRYPSIN
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DE MEXICO SA DE CV·Registered July 17, 2019REACTIVO PARA LA DETERMINACION DE ALFA 1 ANTITRIPSINA
REAGENT FOR THE DETERMINATION OF ALPHA 1 ANTITRYPSIN
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACION DE ALFA 1 ANTITRIPSINA
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF ALPHA 1 ANTITRYPSIN
- Analysis ID
- 1353R2019 SSA
- Registration Date
- July 17, 2019
- Name (Spanish)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
- Name (English)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
Access comprehensive regulatory information for ALINITY C A1 ANTITRYPSIN (ALINITY C A1 ANTITRYPSIN) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1353R2019 SSA and manufactured by ABBOTT LABORATORIES DE MEXICO SA DE CV. The device was registered on July 17, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.